About
Pediatric, rare diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
567
By Phase
PHASE3: 4PHASE1/PHASE2: 2PHASE2: 1
By Status
COMPLETED: 4TERMINATED: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06989567Lead Sponsor
A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis
PHASE3Not yet recruiting
120 participants
Started: Jul 25, 2025 · Completed: Jun 30, 2029
NCT05253209Lead Sponsor
A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
PHASE3Terminated
64 participants
Started: Jun 29, 2022 · Completed: May 10, 2024
NCT04852172Lead Sponsor
L-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive Crisis (VOC)
PHASE1/PHASE2Terminated
30 participants
Started: Apr 29, 2021 · Completed: Feb 29, 2024
NCT04570384Lead Sponsor
Intravenous L-Citrulline Influence on the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19
PHASE2Completed
65 participants
Started: Oct 15, 2020 · Completed: Sep 30, 2021
NCT02891837Lead Sponsor
L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects
PHASE3Completed
189 participants
Started: Aug 31, 2016 · Completed: Jul 31, 2019
Locations (1)
Headquarters
Baltimore, MD, United States
Map
Loading map...